{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:55Z","timestamp":1790610835514,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"am","delay-in-days":266,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.neurobiolaging.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T01:51:03Z","timestamp":1651542663000},"page":"12-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-203X","authenticated-orcid":false,"given":"Ruocheng","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5954-5062","authenticated-orcid":false,"given":"Diandra N.","family":"Denier-Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongshi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne","family":"Suridjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendlyn","family":"Kollmorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8856-1352","authenticated-orcid":false,"given":"Tobey James","family":"Betthauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-5607","authenticated-orcid":false,"given":"Corinne D.","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0001","doi-asserted-by":"crossref","unstructured":"Antonell, A., Tort-Merino, A., R\u00edos, J., Balasa, M., Borrego-\u00c9cija, S., Auge, J.M., Mu\u00f1oz-Garc\u00eda, C., Bosch, B., Falg\u00e0s, N., Rami, L., Ramos-Campoy, O., Blennow, K., Zetterberg, H., Molinuevo, J.L., Llad\u00f3, A., S\u00e1nchez-Valle, R., 2019. Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias. Alzheimer's & Dementia. doi:10.1016\/j.jalz.2019.09.001.","DOI":"10.1016\/j.jalz.2019.09.001"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0002","doi-asserted-by":"crossref","unstructured":"Arendash, G.W., Schleif, W., Rezai-Zadeh, K., Jackson, E.K., Zacharia, L.C., Cracchiolo, J.R., Shippy, D., Tan, J., 2006. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain \u03b2-amyloid production. Neuroscience 142, 941\u2013952. doi:10.1016\/j.neuroscience.2006.07.021.","DOI":"10.1016\/j.neuroscience.2006.07.021"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0003","doi-asserted-by":"crossref","unstructured":"Ashburner, J., Friston, K.J., 2005. Unified segmentation. Neuroimage 26, 839\u2013851. doi:10.1016\/j.neuroimage.2005.02.018.","DOI":"10.1016\/j.neuroimage.2005.02.018"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0004","doi-asserted-by":"crossref","unstructured":"Bendlin, B.B., Carlsson, C.M., Johnson, S.C., Zetterberg, H., Blennow, K., Willette, A.A., Okonkwo, O.C., Sodhi, A., Ries, M.L., Birdsill, A.C., Alexander, A.L., Rowley, H.A., Puglielli, L., Asthana, S., Sager, M.A., 2012. CSF T-Tau\/A\u03b242 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS One 7. doi:10.1371\/journal.pone.0037720.","DOI":"10.1371\/journal.pone.0037720"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0005","doi-asserted-by":"crossref","unstructured":"Bettcher, B.M., Johnson, S.C., Fitch, R., Casaletto, K.B., Heffernan, K.S., Asthana, S., Zetterberg, H., Blennow, K., Carlsson, C.M., Neuhaus, J., Bendlin, B.B., Kramer, J.H., 2018. Cerebrospinal fluid and plasma levels of inflammation differentially relate to CNS markers of Alzheimer's disease pathology and neuronal damage. JAD 62, 385\u2013397. doi:10.3233\/JAD-170602.","DOI":"10.3233\/JAD-170602"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0006","doi-asserted-by":"crossref","unstructured":"Bridgewater BR, E.A., 2014. High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput Profiling metabolomics. Metabolomics 04. doi:10.4172\/2153-0769.1000132.","DOI":"10.4172\/2153-0769.1000132"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0007","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"Metabo Analyst 4.0: towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic. Acids Res."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0008","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-160195","article-title":"Pathway-specific polygenic risk scores as predictors of \u03b2-amyloid deposition and cognitive function in a sample at increased risk for Alzheimer\u2019s disease","volume":"55","author":"Darst","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0009","doi-asserted-by":"crossref","unstructured":"Darst, B.F., Lu, Q., Johnson, S.C., Engelman, C.D., 2019. Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participants. Genet. Epidemiol. 43, 657\u2013674. doi:10.1002\/gepi.22211.","DOI":"10.1002\/gepi.22211"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0010","doi-asserted-by":"crossref","unstructured":"de Leeuw, F.A., van der Flier, W.M., Tijms, B.M., Scheltens, P., Mendes, V.M., Manadas, B., Bierau, J., van Wijk, N., van den Heuvel, E.G.H.M., Mohajeri, M.H., Teunissen, C.E., Kester, M.I., 2020. Specific nutritional biomarker profiles in mild cognitive impairment and subjective cognitive decline are associated with clinical progression: the NUDAD project. J. Am. Med. Dir. Assoc. 21, 1513.e1-1513.e17. doi:10.1016\/j.jamda.2019.12.009.","DOI":"10.1016\/j.jamda.2019.12.009"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0011","doi-asserted-by":"crossref","unstructured":"Denburg, M.R., Xu, Y., Abraham, A.G., Coresh, J., Chen, J., Grams, M.E., Feldman, H.I., Kimmel, P.L., Rebholz, C.M., Rhee, E.P., Vasan, R.S., Warady, B.A., Furth, S.L., 2021. Metabolite biomarkers of CKD progression in children. CJASN 16, 1178\u20131189.","DOI":"10.2215\/CJN.00220121"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0013","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/jnr.24048","article-title":"Metabolomic-guided discovery of Alzheimer\u2019s disease biomarkers from body fluid: Metabolomic-based Alzheimer\u2019s Disease Biomarkers","volume":"95","author":"Enche Ady","year":"2017","journal-title":"J. Neuro. Res."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0014","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1039\/C5FO00052A","article-title":"Catecholaminergic and cholinergic systems of mouse brain are modulated by LMN diet, rich in theobromine, polyphenols and polyunsaturated fatty acids","volume":"6","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2015","journal-title":"Food Funct"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0015","doi-asserted-by":"crossref","unstructured":"Green, K.N., Steffan, J.S., Martinez-Coria, H., Sun, X., Schreiber, S.S., Thompson, L.M., LaFerla, F.M., 2008. Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau. J. Neurosci. 28, 11500\u201311510. doi:10.1523\/JNEUROSCI.3203-08.2008.","DOI":"10.1523\/JNEUROSCI.3203-08.2008"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00216-016-0003-1","article-title":"High-throughput and simultaneous quantitative analysis of homocysteine\u2013methionine cycle metabolites and co-factors in blood plasma and cerebrospinal fluid by isotope dilution LC\u2013MS\/MS","volume":"409","author":"Guiraud","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0017","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2202-10-110","article-title":"Regulation of cerebrospinal fluid production by caffeine consumption","volume":"10","author":"Han","year":"2009","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0018","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome. Biol."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0019","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3233\/JAD-180711","article-title":"Metabolomics analyses of saliva detect novel biomarkers of Alzheimer\u2019s disease","volume":"65","author":"Huan","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0020","doi-asserted-by":"crossref","unstructured":"Jandova, Z., Gill, S.C., Lim, N.M., Mobley, D.L., Oostenbrink, C., 2019. Binding modes and metabolism of caffeine. Chem. Res. Toxicol. 32, 1374\u20131383. doi:10.1021\/acs.chemrestox.9b00030.","DOI":"10.1021\/acs.chemrestox.9b00030"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0021","doi-asserted-by":"crossref","unstructured":"Johnson, S.C., Christian, B.T., Okonkwo, O.C., Oh, J.M., Harding, S., Xu, G., Hillmer, A.T., Wooten, D.W., Murali, D., Barnhart, T.E., Hall, L.T., Racine, A.M., Klunk, W.E., Mathis, C.A., Bendlin, B.B., Gallagher, C.L., Carlsson, C.M., Rowley, H.A., Hermann, B.P., Dowling, N.M., Asthana, S., Sager, M.A., 2014. Amyloid burden and neural function in people at risk for Alzheimer's Disease. Neurobiol. Aging 35, 576\u2013584. doi:10.1016\/j.neurobiolaging.2013.09.028.","DOI":"10.1016\/j.neurobiolaging.2013.09.028"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0022","doi-asserted-by":"crossref","unstructured":"Johnson, S.C., Koscik, R.L., Jonaitis, E.M., Clark, L.R., Mueller, K.D., Berman, S.E., Bendlin, B.B., Engelman, C.D., Okonkwo, O.C., Hogan, K.J., Asthana, S., Carlsson, C.M., Hermann, B.P., Sager, M.A., 2018. The wisconsin registry for alzheimer's prevention: a review of findings and current directions. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 10, 130\u2013142. doi:10.1016\/j.dadm.2017.11.007.","DOI":"10.1016\/j.dadm.2017.11.007"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0023","doi-asserted-by":"crossref","unstructured":"Jolliffe, I., 2005. Principal Component Analysis, in: Encyclopedia of Statistics in Behavioral Science. John Wiley & Sons, Ltd. doi:10.1002\/0470013192.bsa501.","DOI":"10.1002\/0470013192.bsa501"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic. Acids Res."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0025","doi-asserted-by":"crossref","unstructured":"Koal, T., Klavins, K., Seppi, D., Kemmler, G., Humpel, C., 2015. Sphingomyelin SM(d18:1\/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological Amyloid-\u03b2 42, Tau, and Phospho-Tau-181 levels. J. Alzheimer's Dis. 44, 1193\u20131201. doi:10.3233\/JAD-142319.","DOI":"10.3233\/JAD-142319"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0026","doi-asserted-by":"crossref","unstructured":"Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., M\u00fcller, C.E., Bu\u00e9e, L., Blum, D., 2014. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiol. Aging 35, 2079\u20132090. doi:10.1016\/j.neurobiolaging.2014.03.027.","DOI":"10.1016\/j.neurobiolaging.2014.03.027"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0027","doi-asserted-by":"crossref","unstructured":"Lindsay, J., 2002. Risk factors for alzheimer's disease: a prospective analysis from the canadian study of health and aging. Am. J. Epidemiol. 156, 445\u2013453. doi:10.1093\/aje\/kwf074.","DOI":"10.1093\/aje\/kwf074"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0028","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/jpet.104.079319","article-title":"Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding","volume":"313","author":"Liu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0029","unstructured":"Lopresti, B.J., Klunk, W.E., Mathis, C.A., Hoge, J.A., Ziolko, S.K., Lu, X., Meltzer, C.C., Schimmel, K., Tsopelas, N.D., DeKosky, S.T., Price, J.C., 2005. Simplified quantification of pittsburgh compound B Amyloid imaging PET studies: a comparative analysis. J. Nucl. Med. 46, 1959\u20131972."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0030","doi-asserted-by":"crossref","unstructured":"Mil\u00e0-Alom\u00e0, M., Salvad\u00f3, G., Gispert, J.D., Vilor-Tejedor, N., Grau-Rivera, O., Sala-Vila, A., S\u00e1nchez-Benavides, G., Arenaza-Urquijo, E.M., Crous-Bou, M., Gonz\u00e1lez-de-Ech\u00e1varri, J.M., Minguillon, C., Fauria, K., Simon, M., Kollmorgen, G., Zetterberg, H., Blennow, K., Su\u00e1rez-Calvet, M., Molinuevo, J.L., 2020. Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum. Alzheimer's & Dementia 16, 1358\u20131371. doi:10.1002\/alz.12131.","DOI":"10.1002\/alz.12131"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0031","doi-asserted-by":"crossref","unstructured":"Neth, B.J., Mintz, A., Whitlow, C., Jung, Y., Solingapuram Sai, K., Register, T.C., Kellar, D., Lockhart, S.N., Hoscheidt, S., Maldjian, J., Heslegrave, A.J., Blennow, K., Cunnane, S.C., Castellano, C.-A., Zetterberg, H., Craft, S., 2020. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study. Neurobiol. Aging 86, 54\u201363. doi:10.1016\/j.neurobiolaging.2019.09.015.","DOI":"10.1016\/j.neurobiolaging.2019.09.015"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0032","doi-asserted-by":"crossref","first-page":"W423","DOI":"10.1093\/nar\/gkn282","article-title":"KEGG Atlas mapping for global analysis of metabolic pathways","volume":"36","author":"Okuda","year":"2008","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0033","doi-asserted-by":"crossref","unstructured":"O\u00f1atibia-Astibia, A., Franco, R., Mart\u00ednez-Pinilla, E., 2017. Health benefits of methylxanthines in neurodegenerative diseases. Mol. Nutr. Food Res. 61, 1600670. doi:10.1002\/mnfr.201600670.","DOI":"10.1002\/mnfr.201600670"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0034","doi-asserted-by":"crossref","unstructured":"Paglia, G., Stocchero, M., Cacciatore, S., Lai, S., Angel, P., Alam, M.T., Keller, M., Ralser, M., Astarita, G., 2016. Unbiased metabolomic investigation of alzheimer's disease brain points to dysregulation of mitochondrial aspartate metabolism. J. Proteome Res. 15, 608\u2013618. doi:10.1021\/acs.jproteome.5b01020.","DOI":"10.1021\/acs.jproteome.5b01020"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12603-014-0563-8","article-title":"Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review","volume":"19","author":"Panza","year":"2015","journal-title":"J. Nutr. Health Aging."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0036","doi-asserted-by":"crossref","unstructured":"Patenaude, B., Smith, S.M., Kennedy, D.N., Jenkinson, M., 2011. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56, 907\u2013922. doi:10.1016\/j.neuroimage.2011.02.046.","DOI":"10.1016\/j.neuroimage.2011.02.046"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0037","doi-asserted-by":"crossref","unstructured":"Racine, A.M., Koscik, R.L., Berman, S.E., Nicholas, C.R., Clark, L.R., Okonkwo, O.C., Rowley, H.A., Asthana, S., Bendlin, B.B., Blennow, K., Zetterberg, H., Gleason, C.E., Carlsson, C.M., Johnson, S.C., 2016. Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife. Brain 139, 2261\u20132274. doi:10.1093\/brain\/aww142.","DOI":"10.1093\/brain\/aww142"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0038","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","article-title":"Untargeted metabolomics strategies \u2013 challenges and emerging directions","volume":"27","author":"Schrimpe-Rutledge","year":"2016","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0039","doi-asserted-by":"crossref","unstructured":"Sprecher, K.E., Bendlin, B.B., Racine, A.M., Okonkwo, O.C., Christian, B.T., Koscik, R.L., Sager, M.A., Asthana, S., Johnson, S.C., Benca, R.M., 2015. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults. Neurobiol. Aging 36, 2568\u20132576. doi:10.1016\/j.neurobiolaging.2015.05.004.","DOI":"10.1016\/j.neurobiolaging.2015.05.004"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0040","doi-asserted-by":"crossref","unstructured":"Toledo, J.B., Arnold, M., Kastenm\u00fculler, G., Chang, R., Baillie, R.A., Han, X., Thambisetty, M., Tenenbaum, J.D., Suhre, K., Thompson, J.W., St. John-Williams, L., MahmoudianDehkordi, S., Rotroff, D.M., Jack, J.R., Motsinger-Reif, A., Risacher, S.L., Blach, C., Lucas, J.E., Massaro, T., Louie, G., Zhu, H., Dallmann, G., Klavins, K., Koal, T., Kim, S., Nho, K., Shen, L., Casanova, R., Varma, S., Legido-Quigley, C., Moseley, M.A., Zhu, K., Henrion, M.Y.R., van der Lee, S.J., Harms, A.C., Demirkan, A., Hankemeier, T., van Duijn, C.M., Trojanowski, J.Q., Shaw, L.M., Saykin, A.J., Weiner, M.W., Doraiswamy, P.M., Kaddurah-Daouk, R., 2017. Metabolic network failures in Alzheimer's disease: a biochemical road map. Alzheimers Dement 13, 965\u2013984. doi:10.1016\/j.jalz.2017.01.020.","DOI":"10.1016\/j.jalz.2017.01.020"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0041","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-150374","article-title":"Does caffeine consumption modify cerebrospinal fluid amyloid-\u03b2 levels in&patients with alzheimer\u2019s disease?","volume":"47","author":"Travassos","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0042","article-title":"Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in A\u03b2(1-42)-induced rat model of Alzheimer\u2019s disease","volume":"48","author":"Turunc","year":"2013","journal-title":"Free Radical. Res."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0043","doi-asserted-by":"crossref","unstructured":"Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., Joliot, M., 2002. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273\u2013289. doi:10.1006\/nimg.2001.0978.","DOI":"10.1006\/nimg.2001.0978"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0044","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40199-018-0221-5","article-title":"Nicotinamide loaded functionalized solid lipid nanoparticles improves cognition in Alzheimer\u2019s disease animal model by reducing Tau hyperphosphorylation","volume":"26","author":"Vakilinezhad","year":"2018","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3233\/JAD-2012-111799","article-title":"Polyphenol-rich foods in the mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk","volume":"29","author":"Valls-Pedret","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0046","doi-asserted-by":"crossref","unstructured":"Van Hulle, C., Jonaitis, E.M., Betthauser, T.J., Batrla, R., Wild, N., Kollmorgen, G., Andreasson, U., Okonkwo, O., Bendlin, B.B., Asthana, S., Carlsson, C.M., Johnson, S.C., Zetterberg, H., Blennow, K., 2020. An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum. Alzheimers Dement. doi:10.1002\/alz.12204.","DOI":"10.1002\/alz.12204"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0047","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-122371","article-title":"Caffeine and cognitive decline in elderly women at high vascular risk","volume":"35","author":"Vercambre","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0048","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13195-018-0451-2","article-title":"The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease","volume":"10","author":"Vogt","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0049","doi-asserted-by":"crossref","unstructured":"Wang, X., Li, J., Zhang, A.-H., 2016. Urine metabolic phenotypes analysis of extrahepatic cholangiocarcinoma disease using ultra-high performance liquid chromatography-mass spectrometry. RSC Adv. 6, 63049\u201363057. doi:10.1039\/C6RA09430A.","DOI":"10.1039\/C6RA09430A"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00719","article-title":"Application of Metabolomics in Alzheimer\u2019s Disease","volume":"8","author":"Wilkins","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0051","doi-asserted-by":"crossref","unstructured":"Wu, M.-S., Lan, T.-H., Chen, C.-M., Chiu, H.-C., Lan, T.-Y., 2011. Socio-demographic and health-related factors associated with cognitive impairment in the elderly in Taiwan. BMC Public Health 11, 22. doi:10.1186\/1471-2458-11-22.","DOI":"10.1186\/1471-2458-11-22"},{"key":"10.1016\/j.neurobiolaging.2022.04.009_bib0052","doi-asserted-by":"crossref","unstructured":"Xu, K., Xu, Y.-H., Chen, J.-F., Schwarzschild, M.A., 2010. Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience 167, 475\u2013481. doi:10.1016\/j.neuroscience.2010.02.020.","DOI":"10.1016\/j.neuroscience.2010.02.020"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:41:25Z","timestamp":1759318885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458022000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":52,"alternative-id":["S0197458022000835"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.04.009","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}